Association between tumor mutation burden (TMB) and MLH1, PMS2, MSH2, and MSH6 alterations in 395 microsatellite instability-high (MSI-High) gastrointestinal (GI) tumors

  • Salem M
  • Grothey A
  • Goldberg R
  • et al.
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction: Correlation between TMB and objective response to checkpoint inhibitors has been shown. MSI-High tumors usually exhibit high TMB. Relationship between the level of TMB and alterations in the four-mismatch repair deficiency (MMR) genes in gastrointestinal tumors has not been comprehensively studied.Methods: MSI-High status was determined by examining altered microsatellite (MS) loci using NextGen sequencing (cutoff: > =46) on a 592-gene panel. TMB was calculated by enumerating somatic missense mutations. MMR protein expression was evaluated by IHC. ANOVA and chi-square tests were used for comparisons.

Cite

CITATION STYLE

APA

Salem, M., Grothey, A., Goldberg, R., Xiu, J., Korn, W., Shields, A., … Marshall, J. (2018). Association between tumor mutation burden (TMB) and MLH1, PMS2, MSH2, and MSH6 alterations in 395 microsatellite instability-high (MSI-High) gastrointestinal (GI) tumors. Annals of Oncology, 29, v109. https://doi.org/10.1093/annonc/mdy149.024

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free